CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Nano-X Imaging Ltd. - NNOX CFD

    6.85
    2.54%
    0.08
    Low: 6.33
    High: 6.92
    Market Trading Hours* (UTC) Opens on Monday at 14:30

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.08
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026235 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026235%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.004012 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.004012%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 6.68
    Open* 6.38
    1-Year Change* -39.87%
    Day's Range* 6.33 - 6.92
    52 wk Range 4.89-22.69
    Average Volume (10 days) 690.25K
    Average Volume (3 months) 19.07M
    Market Cap 355.63M
    P/E Ratio -100.00K
    Shares Outstanding 57.73M
    Revenue 9.60M
    EPS -1.90
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Nov 28, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 6.68 -0.08 -1.18% 6.76 6.81 6.54
    Nov 29, 2023 6.72 0.33 5.16% 6.39 7.00 6.35
    Nov 28, 2023 6.44 0.21 3.37% 6.23 6.49 5.68
    Nov 27, 2023 6.27 -0.31 -4.71% 6.58 6.58 6.26
    Nov 24, 2023 6.58 0.29 4.61% 6.29 6.71 6.28
    Nov 22, 2023 6.26 0.05 0.81% 6.21 6.34 6.15
    Nov 21, 2023 6.13 -0.36 -5.55% 6.49 6.49 6.04
    Nov 20, 2023 6.55 -0.10 -1.50% 6.65 6.84 6.53
    Nov 17, 2023 6.51 0.15 2.36% 6.36 6.52 6.26
    Nov 16, 2023 6.35 -0.23 -3.50% 6.58 6.69 6.19
    Nov 15, 2023 6.60 0.41 6.62% 6.19 6.82 6.08
    Nov 14, 2023 6.14 0.28 4.78% 5.86 6.22 5.86
    Nov 13, 2023 5.72 0.26 4.76% 5.46 5.77 5.37
    Nov 10, 2023 5.60 0.15 2.75% 5.45 5.62 5.25
    Nov 9, 2023 5.36 -0.27 -4.80% 5.63 5.72 5.32
    Nov 8, 2023 5.60 -0.27 -4.60% 5.87 5.95 5.56
    Nov 7, 2023 5.92 0.28 4.96% 5.64 6.01 5.58
    Nov 6, 2023 5.66 -0.39 -6.45% 6.05 6.05 5.54
    Nov 3, 2023 6.04 0.12 2.03% 5.92 6.23 5.79
    Nov 2, 2023 5.75 0.60 11.65% 5.15 5.78 5.15

    Nano-X Imaging Ltd. Events

    Time (UTC) Country Event
    Monday, December 4, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Nano-X Imaging Ltd Investor Day
    Nano-X Imaging Ltd Investor Day

    Forecast

    -

    Previous

    -
    Thursday, March 7, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Nano-X Imaging Ltd Earnings Release
    Q4 2023 Nano-X Imaging Ltd Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 8.578 1.304 0 0 0
    Total Operating Expense 126.288 62.862 43.923 22.571 1.904
    Selling/General/Admin. Expenses, Total 36.492 37.266 34.713 19.854 1.232
    Research & Development 26.507 17.122 9.21 2.717 0.672
    Operating Income -117.71 -61.558 -43.923 -22.571 -1.904
    Other, Net 0.108 0.008 -0.005
    Net Income Before Taxes -116.921 -61.846 -43.815 -22.563 -1.909
    Net Income After Taxes -113.243 -61.798 -43.815 -22.563 -1.909
    Net Income Before Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
    Net Income -113.243 -61.798 -43.815 -22.563 -1.909
    Income Available to Common Excl. Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
    Income Available to Common Incl. Extra. Items -113.243 -61.798 -43.815 -22.563 -1.909
    Diluted Net Income -113.243 -61.798 -43.815 -22.563 -1.909
    Diluted Weighted Average Shares 52.235 48.216 35.654 44.3939 44.3939
    Diluted EPS Excluding Extraordinary Items -2.16795 -1.28169 -1.22889 -0.50825 -0.043
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -1.42338 -1.22135 -1.22889 -0.50825 -0.043
    Revenue 8.578 1.304
    Cost of Revenue, Total 15.458 2.816
    Gross Profit -6.88 -1.512
    Unusual Expense (Income) 59.663 4.476
    Other Operating Expenses, Total -12.185 1.182
    Interest Income (Expense), Net Non-Operating 0.789 -0.288
    Depreciation / Amortization 0.353
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 2.582 2.447 2.132 2.438 2.2
    Total Operating Expense 20.413 14.525 55.888 22.267 24.383
    Selling/General/Admin. Expenses, Total 6.183 6.628 6.119 8.589 10.065
    Research & Development 6.913 6.286 7.095 6.089 6.493
    Unusual Expense (Income) 2.181 2.236 40.1 3.595 3.773
    Operating Income -17.831 -12.078 -53.756 -19.829 -22.183
    Other, Net
    Net Income Before Taxes -17.451 -11.855 -53.869 -19.524 -21.712
    Net Income After Taxes -17.364 -11.761 -52.837 -19.126 -19.614
    Net Income Before Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
    Net Income -17.364 -11.761 -52.837 -19.126 -19.614
    Income Available to Common Excl. Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
    Income Available to Common Incl. Extra. Items -17.364 -11.761 -52.837 -19.126 -19.614
    Diluted Net Income -17.364 -11.761 -52.837 -19.126 -19.614
    Diluted Weighted Average Shares 55.375 55.157 52.4 52.276 52.192
    Diluted EPS Excluding Extraordinary Items -0.31357 -0.21323 -1.00834 -0.36587 -0.3758
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.28797 -0.18688 -0.51092 -0.32117 -0.32882
    Revenue 2.582 2.447 2.132 2.438 2.2
    Cost of Revenue, Total 4.273 3.97 3.879 3.897 3.955
    Gross Profit -1.691 -1.523 -1.747 -1.459 -1.755
    Other Operating Expenses, Total 0.766 -4.692 -1.305 0 0
    Interest Income (Expense), Net Non-Operating 0.38 0.223 -0.113 0.305 0.471
    Depreciation / Amortization 0.097 0.097 0.097 0.097
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 82.461 94.857 219.793 9.636 1.699
    Cash and Short Term Investments 77.624 88.711 213.468 8.072 0.005
    Cash & Equivalents 38.463 66.645 213.468 8.072 0.005
    Prepaid Expenses 2.414 3.129 6.325 1.564 1.694
    Total Assets 253.933 363.17 236.149 11.871 1.855
    Property/Plant/Equipment, Total - Net 44.702 39.16 15.379 0.754 0.156
    Property/Plant/Equipment, Total - Gross 46.365 40.028 15.723 0.89 0.239
    Accumulated Depreciation, Total -1.663 -0.868 -0.344 -0.136 -0.083
    Other Long Term Assets, Total 2.933 1.184 0.977 1.481 0
    Total Current Liabilities 25.074 52.751 4.48 20.263 8.239
    Accounts Payable 3.619 3.134 0.435 0.475 0.082
    Accrued Expenses 12.98 4.492 4.045 1.968 0
    Notes Payable/Short Term Debt 0 0.145 0 0 0
    Other Current Liabilities, Total 8.475 44.98 17.82 8.157
    Total Liabilities 37.253 71.022 5.403 20.649 8.239
    Total Long Term Debt 3.481 3.796 0 0 0
    Other Liabilities, Total 5.368 7.412 0.923 0.386 0
    Total Equity 216.68 292.148 230.746 -8.778 -6.384
    Common Stock 0.158 0.149 0.131 0.075 0.058
    Additional Paid-In Capital 477.953 438.82 315.031 31.748 11.596
    Retained Earnings (Accumulated Deficit) -259.457 -146.214 -84.416 -40.601 -18.038
    Total Liabilities & Shareholders’ Equity 253.933 363.17 236.149 11.871 1.855
    Total Common Shares Outstanding 55.0942 51.7914 46.1002 44.3939 44.3939
    Short Term Investments 39.161 22.066
    Total Receivables, Net 0.977 1.051
    Accounts Receivable - Trade, Net 0.977 1.051
    Other Current Assets, Total 1.446 1.966
    Goodwill, Net 7.42 58.298
    Intangibles, Net 91.219 101.826
    Long Term Investments 25.198 67.845
    Long Term Debt 3.481 3.796
    Deferred Income Tax 3.33 7.063
    Other Equity, Total -1.974 -0.607
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total Current Assets 77.519 81.855 82.461 90.61 89.766
    Cash and Short Term Investments 74.464 78.091 77.624 88.037 86.634
    Cash & Equivalents 41.998 37.571 38.463 40.331 51.676
    Prepaid Expenses 0.901 1.501 2.414 0.103 0.804
    Total Assets 224.885 238.965 253.933 305.686 317.724
    Property/Plant/Equipment, Total - Net 46.453 46.588 44.702 45.367 44.456
    Other Long Term Assets, Total 1.76 1.718 2.933 2.858 2.954
    Total Current Liabilities 23.433 24.167 25.074 43.592 40.612
    Accounts Payable 3.967 3.716 3.619 5.588 1.858
    Accrued Expenses 13.205 12.903 12.98 2.909 3.801
    Notes Payable/Short Term Debt 0 0 0 0.145 0.145
    Total Liabilities 31.35 32.235 37.253 57.854 55.448
    Total Long Term Debt 3.428 3.451 3.481 3.481 3.481
    Other Liabilities, Total 1.347 1.381 5.368 6.443 6.588
    Total Equity 193.535 206.73 216.68 247.832 262.276
    Common Stock 0.159 0.158 0.158 0.15 0.15
    Additional Paid-In Capital 482.971 479.172 477.953 456.761 451.825
    Retained Earnings (Accumulated Deficit) -288.582 -271.218 -259.457 -206.62 -187.494
    Total Liabilities & Shareholders’ Equity 224.885 238.965 253.933 305.686 317.724
    Total Common Shares Outstanding 55.5598 55.1503 55.0942 52.2665 52.2147
    Short Term Investments 32.466 40.52 39.161 47.706 34.958
    Long Term Investments 5.82 12.818 25.198 29.023 40.067
    Other Equity, Total -1.013 -1.382 -1.974 -2.459 -2.205
    Long Term Debt 3.428 3.451 3.481 3.481 3.481
    Total Receivables, Net 1.431 1.308 0.977 1.121 1.203
    Accounts Receivable - Trade, Net 1.431 1.308 0.977 1.121 1.203
    Other Current Assets, Total 0.723 0.955 1.446 1.349 1.125
    Goodwill, Net 7.42 7.42 7.42 43.96 43.96
    Intangibles, Net 85.913 88.566 91.219 93.868 96.521
    Other Current Liabilities, Total 6.261 7.548 8.475 34.95 34.808
    Deferred Income Tax 3.142 3.236 3.33 4.338 4.767
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -113.243 -61.798 -43.815 -22.563 -1.909
    Cash From Operating Activities -43.385 -38.071 -21.487 -5.524 -3.671
    Cash From Operating Activities 0.905 0.524 0.208 0.053 0.035
    Non-Cash Items 71.024 18.804 24.781 16.245 0.115
    Changes in Working Capital -8.945 2.747 -2.661 0.741 -1.912
    Cash From Investing Activities 14.606 -116.32 -13.937 -0.125 -0.073
    Capital Expenditures -7.171 -23.158 -13.937 -0.125 -0.073
    Cash From Financing Activities 0.804 7.379 240.991 13.861 3.684
    Financing Cash Flow Items -0.145 0 -0.339 0
    Issuance (Retirement) of Stock, Net 0.949 3.583 240.991 14.2 3.684
    Net Change in Cash -28.243 -147.012 205.567 8.212 -0.06
    Amortization 10.607 1.768
    Deferred Taxes -3.733 -0.116
    Other Investing Cash Flow Items, Total 21.777 -93.162
    Issuance (Retirement) of Debt, Net 0 3.796
    Cash Taxes Paid 0.147
    Cash Interest Paid 0.09
    Foreign Exchange Effects -0.268
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -11.761 -113.243 -60.406 -41.28 -21.666
    Cash From Operating Activities -10.674 -43.385 -30.507 -22.284 -10.955
    Cash From Operating Activities 0.255 0.905 0.626 0.404 0.206
    Amortization 2.653 10.607 7.958 5.305 2.653
    Deferred Taxes -0.094 -3.733 -2.725 -2.296 -0.178
    Non-Cash Items 1.671 71.024 29.927 25.415 6.946
    Changes in Working Capital -3.398 -8.945 -5.887 -9.832 1.084
    Cash From Investing Activities 9.616 14.606 3.501 -6.77 -1.12
    Capital Expenditures -1.495 -7.171 -7.387 -5.76 -3.815
    Other Investing Cash Flow Items, Total 11.111 21.777 10.888 -1.01 2.695
    Cash From Financing Activities 0.176 0.804 0.63 14.082 0.387
    Financing Cash Flow Items -0.145 13.557
    Issuance (Retirement) of Stock, Net 0.176 0.949 0.63 0.525 0.387
    Issuance (Retirement) of Debt, Net 0 0
    Net Change in Cash -0.893 -28.243 -26.376 -14.972 -11.724
    Cash Taxes Paid 0 0.116
    Cash Interest Paid 0.04 0.017
    Foreign Exchange Effects -0.011 -0.268 -0.036
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3558 3068536 305570 2023-06-30 LOW
    Poliakine (Ran) Individual Investor 4.5851 2626927 -40 2023-03-31 LOW
    SK Telecom TMT Investment Corp Corporation 4.5511 2607466 0 2023-03-31
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.8941 1085211 114958 2023-06-30 LOW
    Credit Suisse Funds AG Investment Advisor/Hedge Fund 1.1985 686649 8729 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9177 525790 36031 2023-06-30 LOW
    VK Services, LLC Investment Advisor 0.745 426844 0 2023-06-30 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.7205 412811 215048 2023-06-30 LOW
    Susquehanna International Group, LLP Investment Advisor 0.5684 325646 -68347 2023-06-30 MED
    Nuveen LLC Pension Fund 0.5567 318978 154496 2023-06-30 LOW
    Johnson & Johnson Innovation-JJDC, Inc. Venture Capital 0.5545 317704 0 2023-06-30 LOW
    Jane Street Capital, L.L.C. Research Firm 0.5261 301397 289470 2023-06-30 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.4562 261355 1862 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.4353 249407 33711 2023-06-30 LOW
    Griffin Asset Management, Inc. Investment Advisor/Hedge Fund 0.4041 231532 -11771 2023-09-30 LOW
    Voloridge Investment Management, LLC Investment Advisor/Hedge Fund 0.3327 190629 190629 2023-06-30 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.3078 176362 -91119 2023-06-30 MED
    ARK Investment Management LLC Investment Advisor 0.2602 149072 -178312 2023-09-30 LOW
    BlackRock Investment Management, LLC Investment Advisor/Hedge Fund 0.2439 139723 3763 2023-06-30 LOW
    Taylor Frigon Capital Management LLC Investment Advisor 0.2149 123104 17706 2023-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Nano-X Imaging Ltd. Company profile

    Nano-X Imaging Ltd. (NNOX) is a medical imaging technology company that develops, manufactures and commercialises digital X-ray source technology based on a novel digital micro-electromechanical systems (MEMS) semiconductor cathode.   

    Founded in 2011 and headquartered in Neve Ilan, Israel, Nano-X Imaging leverages disruptive technology to transform and aid the medical industry.

    The company aims to reduce the cost of medical imaging systems. Its imaging products are designed to transmit all imaging data to the cloud Software as a Service (SaaS) platform, which would employ a matching engine to match scans to radiologists. 

    Nano-X’s proprietary technologies include Nanox.ARC, Nanox.CLOUD and Nanox.TUBE. 

    Nanox.ARC is a medical imaging system that incorporates the novel digital X-ray source, while the Nanox.CLOUD is a companion cloud-based software that allows the delivery of medical screening as a service.

    The Nanox.CART X-Ray System has received United States Food and Drug Administration (FDA) clearance using the Nanox.SOURCE. 

    The company also provides Nanox.CLOUD Services, which is a medical AI system that would provide first response and decision assistive information. 

    Nano-X Imaging went public on the NASDAQ under the ticker symbol ‘NNOX’ in August 2020.

    Industry: Medical Imaging Systems

    Communications Center
    NEVE 'ILAN
    9085000
    IL

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    BTC/USD

    38,832.70 Price
    +2.670% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Gold

    2,072.25 Price
    +1.760% 1D Chg, %
    Long position overnight fee -0.0193%
    Short position overnight fee 0.0111%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading